Wellinks
Wellinks is a US digital health company that delivers virtual-first COPD management — combining Spire Health remote patient monitoring, AI-driven predictive analytics, and virtual pulmonary rehabilitation — through value-based care contracts with Medicare Advantage plans, health systems, and risk-bearing provider networks.
- Company typePrivate
- Founded2022
- HeadquartersNew Haven, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Wellinks does
Wellinks (legal entity Convexity Scientific Inc.) is a US digital health company focused on virtual-first management of chronic obstructive pulmonary disease (COPD). It operates a platform that combines the Spire RPM System — a continuous cardiorespiratory remote patient monitoring stack built around a wearable respiratory sensor (Spire Health Tag) and a cellular Home Hub — with AI-driven Predictive Patient Care and a virtual pulmonary rehabilitation program delivered by a multidisciplinary clinical team. The Spire Health business was acquired in September 2024 in a non-cash transaction, and the pulmonary rehabilitation program was acquired from Sparo in June 2022.
The company's commercial model is enterprise B2B: it sells outcomes-oriented, value-based care contracts to Medicare Advantage plans, Managed Medicaid, commercial insurers, and risk-bearing provider networks, with claimed 3X ROI, $11.3k average annual savings per patient, 65% reduction in hospitalizations, and 45% fewer ER visits. Distribution is through direct field sales into named partners including Highmark Blue Cross Blue Shield Delaware, UMass Memorial Health, Hartford HealthCare, SoNE HEALTH, and CareAbout Health, with geographic concentration in the Northeast plus new footprints in New Jersey and Florida. Revenue is recurring via subscription-style value-based contracts, services are provided at no direct cost to eligible patients, and pricing is not publicly disclosed.
Wellinks is privately held, headquartered in New Haven, Connecticut, backed by venture investors including Morningside, HighCape Capital, Connecticut Innovations, and Benslie, and holds SOC 2 Type 2 and HIPAA compliance. Leadership includes CEO Stacie Bratcher (appointed July 2023), CSO Dr. Abi Sundaramoorthy (formerly CMO), and board member Douglas Wenners.
Wellinks firmographics
Firmographics- Name
- Wellinks
- Legal name
- Convexity Scientific Inc.
- Website
- https://wellinks.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Wellinks is a US digital health company that delivers virtual-first COPD management — combining Spire Health remote patient monitoring, AI-driven predictive analytics, and virtual pulmonary rehabilitation — through value-based care contracts with Medicare Advantage plans, health systems, and risk-bearing provider networks.
- Ownership category
- akta.pro rank
Wellinks industry classification
Industry- Product category
- Digital Health / Remote Patient Monitoring
- NAICS
- Offices of Physicians (6211)
- SIC
- Services-Home Health Care Services (8082), Services-Health Services (8000), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Respiratory & Sleep RPM (COPD, asthma, sleep apnea) (HLALAFAB)
- akta.pro secondary industries
- Chronic Disease Management Pathways (e.g., diabetes, CHF, COPD) (HLACAGAG), Pulmonary Rehabilitation Programs (HLADAJAK), Home Respiratory & Sleep Therapy Providers (DME-Integrated) (HLAFAEAF)
Keywords
Where Wellinks is headquartered
LocationHeadquarters
- HQ city
- New Haven
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Wellinks business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Revenue model
- Value-Based Care Contracts: Wellinks generates revenue through value-based care agreements with health plans and providers, where compensation is tied to measurable outcomes including reductions in hospital admissions, ER visits, and total cost of care. The company demonstrates 3X ROI to payer partners.
- Remote Patient Monitoring Services: RPM monitoring services billed to payers for continuous cardiorespiratory monitoring of COPD patients. Includes Spire device provision, clinical decision support, and care team coordination.
- Virtual Pulmonary Rehabilitation: Virtual pulmonary rehabilitation sessions and programs delivered to patients, billed through value-based care arrangements or fee-for-service RPM codes. Includes coaching, clinical support, and educational resources.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Value-Based Care Partnership Model |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Wellinks product offering
Product offeringCore offering
Wellinks provides a virtual-first integrated COPD management platform combining continuous remote patient monitoring via Spire Health wearable sensor technology, AI-powered predictive analytics, and virtual pulmonary rehabilitation services. The platform captures 2,000-4,000 breaths per day through the Spire Health Tag and uses predictive modeling to detect deviations from patient baselines, enabling early clinical intervention. The offering is delivered to health plans, Medicare Advantage plans, Managed Medicaid, health systems, and value-based care providers under value-based care contracts.
Product overview
Wellinks is a digital healthcare company offering a virtual-first COPD management platform. The core offering consists of the Spire RPM System (acquired from Spire Health in September 2024), which provides continuous cardiopulmonary monitoring through the Spire Health Tag wearable sensor and Spire Home Hub. Built on this remote monitoring foundation is the Predictive Patient Care model, which uses AI-powered analytics to detect health deviations and enable early intervention. The platform also includes Virtual Pulmonary Rehabilitation, providing patients with virtual coaching, clinical support, and educational resources. The Spire RPM System collects 2K-4K breaths per day along with pulse rate, activity, and sleep data, while the Predictive Patient Care model analyzes this data to identify deviations from patient baselines and trigger proactive clinical outreach.
Differentiator
Problem solved
Functional benefit
Brands
- Spire RPM System: Remote patient monitoring system with continuous cardiopulmonary monitoring, predictive analytics, and clinical decision support for COPD and cardiopulmonary care.
- Spire Health Tag
- Predictive Patient Care
Products and services
- Spire RPM System Remote patient monitoring platform that integrates continuous cardiopulmonary monitoring, advanced data algorithms, and clinical decision support for COPD and cardiopulmonary care. The system captures 2,000-4,000 breaths per day along with pulse rate, activity, and sleep data, and includes the Spire Health Tag wearable sensor and cellular Home Hub for automatic data sync. Designed for health plans, Medicare Advantage, Managed Medicaid, and value-based care providers managing COPD populations.
- Predictive Patient Care AI-powered care model that uses predictive analytics and real-time continuous patient monitoring data to detect deviations from patient respiratory baselines, enabling early intervention before symptoms escalate. Reduces hospitalizations and improves cardiopulmonary outcomes through proactive clinical outreach. Built on the Spire RPM System data foundation and delivered to health plans and value-based care providers.
- Virtual Pulmonary Rehabilitation Virtual pulmonary rehabilitation program providing remote COPD management through virtual coaching, personalized one-on-one clinical coaching with certified health coaches, asthma educators, physicians, registered nurses, respiratory therapists, and clinical exercise physiologists, plus educational resources for patients with chronic respiratory diseases. Includes 24/7 nurse triage support and is delivered to health plan and provider partners' member populations.
Quantifiable outcome
- 45% fewer COPD-related ER visits
- +5 more outcomes
Companies that use Wellinks
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles3 records
Wellinks technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature4 records
Wellinks partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core.
- CareAbout HealthcorePartnership to expand virtual-first COPD management programs within value-based care networks. The collaboration aims to improve patient outcomes and reduce hospitalization rates in New Jersey and Florida markets. CareAbout Health provides access to value-based care network infrastructure.
- SoNE HEALTHcoreCollaboration to deliver high quality COPD care to patients in the SoNE HEALTH network. Southern New England Healthcare is a regional leader in value-based care and population health management. The partnership connects COPD patients with Wellinks' virtual pulmonary care services.
- UMass Memorial HealthcoreIntegration of Wellinks' virtual pulmonary rehabilitation program at UMass Memorial Health to support COPD patients in Central Massachusetts. Collaboration with UMMH's Center for Digital Health Solutions and Digital Health Clinic. Builds on ongoing Healthy at Home study with UMass Chan Medical School.
- Highmark Blue Cross Blue Shield DelawarecoreAgreement to deliver high-quality COPD care to underserved populations in Delaware starting July 1, 2023. Partnership aims to reduce access barriers for members with COPD by offering virtual pulmonary rehabilitation care.
- UMass Chan Medical SchoolcoreMulti-year research collaboration including the Healthy at Home study assessing feasibility of app-based consumer technology and comprehensive virtual disease management. Principal investigator Dr. Apurv Soni leading Program in Digital Medicine research partnership.
- COPD FoundationcoreASPIRE clinical trial collaboration to assess impact of Wellinks on quality of life, engagement, and satisfaction among COPD Foundation members. Patient survey conducted to measure program effectiveness and outcomes.
- Hartford HealthCarecorePOWER study partnership to evaluate impact of Wellinks' COPD management program on hospital readmissions for COPD patients. Clinical research collaboration to measure program effectiveness.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
Wellinks competitors and assessment
Company assessmentBroad incumbents
- Vivify Health: RPM platform owned by Optum (UnitedHealth Group) serving chronic and post-acute populations. Comparable RPM technology stack and enterprise health plan distribution, though part of a much broader portfolio.
- Biofourmis: Hospital-at-home and RPM platform with AI-driven predictive analytics for cardiac, respiratory, and oncology patients. Comparable on the predictive RPM + AI analytics axis with a broader condition portfolio.
Direct peers
- Vida Health: Virtual chronic condition management platform combining coaching, mental health, and remote monitoring for diabetes, hypertension, and musculoskeletal conditions. Comparable enterprise health plan GTM and value-based outcomes focus.
- Omada Health: Virtual-first chronic disease management company delivering behavior-change programs for diabetes, hypertension, and musculoskeletal conditions. Comparable as a virtual chronic care platform reimbursed via value-based contracts with payers and employers.
- Lark Health: AI-driven chronic disease coaching platform for diabetes, hypertension, and prediabetes delivered via mobile app with continuous monitoring. Comparable virtual-first chronic care delivery with health plan partnerships.
- Hinge Health: Virtual rehabilitation platform for musculoskeletal conditions combining wearable sensors, AI coaching, and remote physical therapists. Comparable care delivery model (virtual rehab + RPM + clinical coaching) and payer contracting motion.
- Health Recovery Solutions: RPM platform for chronic care management including COPD, CHF, and hypertension delivered to health systems and payers. Comparable enterprise RPM business model and condition focus.
- Propeller Health: Digital respiratory health platform acquired by ResMed; offers connected inhalers and COPD/asthma management software. Most directly comparable peer given overlapping COPD patient population and remote monitoring approach.
Emerging players
- Kaia Health: Digital therapeutics company with programs for musculoskeletal pain and COPD pulmonary rehabilitation. Directly overlaps with Wellinks' virtual pulmonary rehabilitation offering for COPD patients.
- Somnoware Healthcare: Cloud-based platform for sleep and respiratory diagnostics and care management serving health systems and durable medical equipment providers. Adjacent in respiratory/sleep digital health.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Wellinks social profiles
Digital presenceWellinks compliance and trust
Trust signalCompliance2 records
Wellinks financial estimates
Financial estimateRevenue estimate
Valuation estimate
Wellinks leadership team
Management profileNumber of profiles
Profiles3 records
Wellinks subsidiaries and ownership
Company hierarchySubsidiaries1 record
Wellinks funding detail
Funding detailFunding overview
Funding rounds3 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Wellinks M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Wellinks
What does Wellinks do?
Wellinks provides a virtual-first integrated COPD management platform combining continuous remote patient monitoring via Spire Health wearable sensor technology, AI-powered predictive analytics, and virtual pulmonary rehabilitation services. The platform captures 2,000-4,000 breaths per day through the Spire Health Tag and uses predictive modeling to detect deviations from patient baselines, enabling early clinical intervention. The offering is delivered to health plans, Medicare Advantage plans, Managed Medicaid, health systems, and value-based care providers under value-based care contracts.
Is Wellinks a public or private company?
Wellinks is a private company. It is classified as venture growth investor backed and is currently operating.
When was Wellinks founded?
Wellinks was founded in 2022. It employs 11 to 50 people.
Where is Wellinks based?
Wellinks is headquartered in New Haven, United States, in the North America region.
How does Wellinks make money?
Three revenue lines are on record. Value-Based Care Contracts are the primary driver. The others are remote Patient Monitoring Services and virtual Pulmonary Rehabilitation.
Who are Wellinks's main competitors?
Broad incumbents on record are Vivify Health and Biofourmis. Direct peers are Vida Health, Omada Health, Lark Health, Hinge Health, Health Recovery Solutions and Propeller Health. Emerging players are Kaia Health and Somnoware Healthcare.
Does Wellinks have an API?
No public API is recorded for Wellinks.
What industry is Wellinks in?
Wellinks's product category is Digital Health / Remote Patient Monitoring. Its primary akta.pro industry code is HLALAFAB, Respiratory & Sleep RPM (COPD, asthma, sleep apnea), with a secondary code of HLACAGAG, Chronic Disease Management Pathways (e.g., diabetes, CHF, COPD). Its NAICS code is 6211 and its SIC code is 8082.